MICE SENSITIVITY ANALYSIS OF EVENT FREE SURVIVAL IN HIGH-RISK NEUROBLASTOMA PATIENTS RECEIVING EFLORNITHINE (DFMO) MAINTENANCE TREATMENT WITH MATCHED EXTERNAL CONTROLS

被引：0
|
作者：
Kraveka, Jacqueline [1 ]
Oesterheld, Javier [2 ]
Ferguson, William [3 ,4 ]
Bergendahl, Genevieve [5 ]
Clinch, Thomas [6 ]
Staines, Harry [6 ]
Sholler, Giselle Saulnier [2 ]
机构：
[1] MUSC Shawn Jenkins Childrens Hosp, Pediat Hematol Oncol, Charleston, SC USA
[2] Atrium Hlth Levine Childrens Hosp, Pediat Hematol & Oncol, Charlotte, NC USA
[3] St Louis Univ, Sch Med, St Louis, MO USA
[4] St Louis Univ, Cardinal Glennon Childrens Med Ctr, Dept Pediat, Div Hematol Oncol, St Louis, MO USA
[5] Beat Childhood Canc Res Consortium, Charlotte, NC USA
[6] US WorldMeds, Biostats, Louisville, KY USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP335
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis
    Kazutoshi Fujita
    Kei Taneishi
    Teruo Inamoto
    Yu Ishizuya
    Shingo Takada
    Masao Tsujihata
    Go Tanigawa
    Noriko Minato
    Shigeaki Nakazawa
    Tsuyoshi Takada
    Toshichika Iwanishi
    Motohide Uemura
    Yasushi Okuno
    Haruhito Azuma
    Nonomura Norio
    BMC Urology, 17
  • [42] Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis
    Markovina, Stephanie
    Meeks, Marshall W.
    Badiyan, Shahed
    Vetter, Joel
    Gay, Hiram A.
    Paradis, Alethea
    Michalski, Jeff
    Sandhu, Gurdarshan
    ADVANCES IN RADIATION ONCOLOGY, 2018, 3 (02) : 190 - 196
  • [43] FLT3 Ligand Kinetic Profile Predicts Response to Treatment and Event-Free Survival (EFS) in Adults with High-Risk MDS/CMML Receiving CPX-351: A GFM Study
    Peterlin, Pierre
    Gaschet, Joelle
    Turlure, Pascal
    Gourin, Marie-Pierre
    Dumas, Pierre-Yves
    Thepot, Sylvain
    Berceanu, Ana
    Park, Sophie
    Cluzeau, Thomas
    Torregrosa-Diaz, Jose-Miguel
    Drevon, Louis
    Sapena, Rosa
    Chermat, Fatiha
    Dimicoli-Salazar, Sophie
    Jullien, Maxime
    Fenaux, Pierre
    Chevallier, Patrice
    BLOOD, 2023, 142
  • [44] Biochemical Relapse-free Survival after External Beam Radiation and Brachytherapy for Prostate Cancer Patients Having Intermediate and High-risk Features
    Shasha, D.
    Nabhani, T.
    Nadelson, A.
    Patton, B.
    Salant, R.
    Harrison, L. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S337 - S337
  • [45] Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort
    Freise, Noemi F.
    Gliga, Smaranda
    Fischer, Johannes
    Lubke, Nadine
    Lutterbeck, Matthias
    Scholer, Miriam
    Bolke, Edwin
    Orth, Hans Martin
    Feldt, Torsten
    Roemmele, Christoph
    Wilke, Dominik
    Schneider, Jochen
    Wille, Kai
    Hohmann, Christian
    Strauss, Richard
    Hower, Martin
    Ruf, Andreas
    Schubert, Joerg
    Isberner, Nora
    Stecher, Melanie
    Pilgram, Lisa
    Vehreschild, Jorg J.
    Hanses, Frank
    Luedde, Tom
    Jensen, Bjorn
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [46] Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort
    Noemi F. Freise
    Smaranda Gliga
    Johannes Fischer
    Nadine Lübke
    Matthias Lutterbeck
    Miriam Schöler
    Edwin Bölke
    Hans Martin Orth
    Torsten Feldt
    Christoph Roemmele
    Dominik Wilke
    Jochen Schneider
    Kai Wille
    Christian Hohmann
    Richard Strauss
    Martin Hower
    Andreas Ruf
    Joerg Schubert
    Nora Isberner
    Melanie Stecher
    Lisa Pilgram
    Jörg J. Vehreschild
    Frank Hanses
    Tom Luedde
    Björn Jensen
    Scientific Reports, 12
  • [47] Do Uninsured Breast Cancer Patients Receive Equal Treatment Despite High-Risk Features? A Propensity Score Matched Analysis
    Prillaman, Paul W.
    Green, Lauren M.
    Collins, Jay N.
    Britt, Rebecca C.
    Burgess, Jessica R.
    Hughes, Marybeth S.
    Perry, Roger R.
    Feliberti, Eric C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S35 - S35
  • [48] Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy
    Yang, David D.
    Muralidhar, Vinayak
    Mahal, Brandon A.
    Nguyen, Paul L.
    Devlin, Phillip M.
    King, Martin T.
    Orio, Peter F., III
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 53 - 58
  • [49] Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
    Berthold, F
    Boos, J
    Burdach, S
    Erttmann, R
    Henze, G
    Hermann, J
    Klingebiel, T
    Kremens, B
    Schilling, FH
    Schrappe, M
    Simon, T
    Hero, B
    LANCET ONCOLOGY, 2005, 6 (09): : 649 - 658
  • [50] Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining 123I-MIBG SPECT-CT radiomics and clinical factors
    Lijuan Feng
    Xu Yang
    Chao Wang
    Hui Zhang
    Wei Wang
    Jigang Yang
    Pediatric Radiology, 2024, 54 : 805 - 819
12345